Ashland Stock Surges on Earnings Beat and Activist Investor Agreement

Ashland Global Holdings (NYSE: ASH) shares surged nearly 6% on Tuesday, driven by a rare dual-catalyst event. The specialty chemicals company announced a settlement with activist investor Ancora Holdings on the same day it reported fiscal third-quarter earnings that surpassed analyst expectations.

A Two-Pronged Catalyst

Ashland reported strong top-line results for the third quarter ending July 28. Key figures from the earnings release include:

• Revenue: $497 million, a 7% year-over-year increase that beat the consensus estimate of $485 million.
• Adjusted EPS: $1.02, slightly ahead of the $1.00 consensus.
• Volume Growth: A notable 6% increase across all business segments, with Life Sciences revenue climbing 11% and Personal Care growing 5%.

Simultaneously, Ashland announced a cooperation agreement with Ancora Holdings. As part of the deal, the company will appoint two new independent directors, Peter Thomas and Allen Spizzo, to its board. A new Capital Allocation Advisory Committee will also be formed to review strategic options.

Activist Deal Viewed as Key Driver

Ad

While the earnings beat was positive, the agreement with Ancora may be the more significant driver for the stock's advance. Ancora had previously advocated for a full sale of the company, estimating a potential takeout price of approximately $76 per share. The board settlement, which includes new directors with M&A experience, is seen by investors as a step toward seriously considering strategic alternatives, including a sale.

Following the news, several analysts updated their outlooks. Wolfe Research raised its price target on Ashland to $78, explicitly citing the activist involvement as a reason for increasing its valuation multiple. Mizuho also reiterated its Outperform rating and lifted its target to $77.

Operational Headwinds Persist

Despite the positive revenue figures, Ashland's report was not without challenges. The company's adjusted EBITDA declined to $109 million from $113 million a year earlier, while its EBITDA margin contracted by 250 basis points to 21.9%. Management attributed the margin pressure to an equipment failure, weather disruptions, and costs associated with a facility transition.

Reflecting these operational issues, Ashland trimmed its full-year EPS growth guidance from mid-to-high single digits to a low-to-mid single-digit range. The presence of a second activist investor, Cruiser Capital Advisors, also adds a layer of complexity to the company's strategic path forward.